MARKET

PCVX

PCVX

Vaxcyte, Inc.
NASDAQ
53.01
+1.53
+2.97%
After Hours: 54.06 +1.05 +1.98% 18:46 05/08 EDT
OPEN
50.82
PREV CLOSE
51.48
HIGH
53.39
LOW
50.82
VOLUME
1.92M
TURNOVER
--
52 WEEK HIGH
65.00
52 WEEK LOW
28.09
MARKET CAP
7.65B
P/E (TTM)
-7.6912
1D
5D
1M
3M
1Y
5Y
1D
Vaxcyte (PCVX) Is Down 10.1% After Wider Q1 Loss But Completing Key VAX-31 Phase 3 Enrollment
Simply Wall St · 21h ago
Guggenheim Remains a Buy on Vaxcyte (PCVX)
TipRanks · 1d ago
Vaxcyte Down Over 10%, On Track for Largest Percent Decrease Since May 2025 -- Data Talk
Dow Jones · 1d ago
Analysts Have Conflicting Sentiments on These Healthcare Companies: Evotec AG (EVO), Vaxcyte (PCVX) and ACADIA Pharmaceuticals (ACAD)
TipRanks · 2d ago
Vaxcyte reports Q1 EPS ($2.30), consensus ($1.77)
TipRanks · 2d ago
Analysts Offer Insights on Healthcare Companies: Vaxcyte (PCVX) and Cross Country Healthcare (CCRN)
TipRanks · 2d ago
Vaxcyte GAAP EPS of -$2.30
Seeking Alpha · 2d ago
Vaxcyte Q1 EPS $(2.30) Misses $(1.82) Estimate
Benzinga · 2d ago
More
About PCVX
Vaxcyte, Inc. is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. The Company's pipeline includes VAX-31, VAX-24 and VAX-XL. VAX-31, a 31-valent PCV candidate being evaluated in the OPUS Phase III adult clinical program and in a Phase II infant clinical program, is being developed for the prevention of IPD and is the broadest-spectrum PCV candidate in the clinic today. VAX-24, a 24-valent PCV candidate, is designed to cover more serotypes than any infant PCV on-market. VAX-XL leverages the Company’s carrier-sparing, site-specific conjugation technology. It is re-engineering the way highly complex vaccines are made through XpressCF, its cell-free protein synthesis platform exclusively licensed from Sutro Biopharma, Inc. Its pipeline also includes VAX-A1, a prophylactic vaccine candidate designed to prevent Group A Strep infections, and VAX-GI, a vaccine candidate designed to prevent Shigella.

Webull offers Vaxcyte Inc stock information, including NASDAQ: PCVX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PCVX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PCVX stock methods without spending real money on the virtual paper trading platform.